Mitsubishi UFJ Asset Management Co. Ltd. Has $76.52 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Kenvue Inc. (NYSE:KVUE) by 4.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 3,609,212 shares of the company’s stock after acquiring an additional 143,861 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.19% of Kenvue worth $76,515,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of KVUE. Alerus Financial NA grew its stake in Kenvue by 0.3% in the third quarter. Alerus Financial NA now owns 191,345 shares of the company’s stock valued at $4,426,000 after purchasing an additional 491 shares in the last quarter. Kiley Juergens Wealth Management LLC grew its stake in shares of Kenvue by 1.9% in the fourth quarter. Kiley Juergens Wealth Management LLC now owns 27,110 shares of the company’s stock valued at $579,000 after buying an additional 500 shares in the last quarter. Principle Wealth Partners LLC increased its holdings in Kenvue by 3.7% during the fourth quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company’s stock worth $303,000 after buying an additional 500 shares during the last quarter. White Pine Capital LLC raised its position in Kenvue by 1.0% during the fourth quarter. White Pine Capital LLC now owns 54,572 shares of the company’s stock worth $1,165,000 after acquiring an additional 542 shares in the last quarter. Finally, Deseret Mutual Benefit Administrators lifted its stake in Kenvue by 29.0% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company’s stock valued at $54,000 after acquiring an additional 568 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on KVUE shares. Canaccord Genuity Group boosted their price objective on shares of Kenvue from $24.00 to $29.00 and gave the stock a “buy” rating in a research note on Wednesday, March 5th. Evercore ISI assumed coverage on Kenvue in a research note on Monday. They issued an “in-line” rating and a $25.00 price objective on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Deutsche Bank Aktiengesellschaft lowered Kenvue from a “buy” rating to a “hold” rating and decreased their target price for the stock from $25.00 to $24.00 in a report on Thursday, December 12th. Finally, Piper Sandler raised their price target on Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Monday, February 24th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus target price of $24.00.

Kenvue Stock Performance

NYSE KVUE opened at $23.52 on Friday. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46. The firm has a 50-day moving average price of $22.27 and a two-hundred day moving average price of $22.46. The company has a market capitalization of $44.95 billion, a P/E ratio of 44.38, a P/E/G ratio of 2.62 and a beta of 1.25. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th were paid a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue’s dividend payout ratio (DPR) is presently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.